Target intelligence / Profile preview

Protein arginine methyltransferase 1 pseudogene 1 (PRMT1P1)

Target
PRMT1P1
Molecular classification
Other — specifically, pseudogene; not classified as enzyme, receptor, transporter, or other functional protein family
01

Overview

Protein arginine methyltransferase 1 pseudogene 1 (PRMT1P1) is a genomic sequence classified as a pseudogene, meaning it closely resembles the coding gene for protein arginine methyltransferase 1 (PRMT1) but does not produce a functional protein[1][3]. Pseudogenes like PRMT1P1 typically arise from gene duplication or retrotransposition and subsequently accumulate disabling mutations, such as premature stop codons or frameshifts, that result in loss of function[3]. PRMT1P1 may be transcribed at low levels, but its RNA product does not have established functional significance. PRMT1P1 is not a receptor, enzyme, or any other therapeutic target, and current evidence does not ascribe it a clinical role in disease or therapy[3]. If you intended to search for the functional protein arginine methyltransferase 1 (PRMT1), then that is a distinct, functional enzyme with established biological, therapeutic, and disease relevance[2][4]. The name "PRMT1P1" refers specifically to the pseudogene and not to the active enzyme.

Other names
PRMT1 pseudogene 1PRMT1P1
02

Mechanism of action

None — mechanism of action information is not applicable to pseudogenes

03

Biological functions

None — as a pseudogene, PRMT1P1 does not perform biological functions under canonical circumstances
04

Disease associations

None — there is no evidence that PRMT1P1 has a direct role in disease; however, some pseudogenes can occasionally have regulatory RNA functions, but there is no specific evidence for PRMT1P1
05

Safety considerations

None — no therapeutic relevance or safety profile, as it is not a target
06

Interacting drugs

None — there are no drugs that directly interact with PRMT1P1, as it is not a functional protein
07

Biomarkers

None — PRMT1P1 is not used as a biomarker for patient selection or monitoring

Beyond the preview

Go deeper on Protein arginine methyltransferase 1 pseudogene 1 (PRMT1P1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Protein arginine methyltransferase 1 pseudogene 1 (PRMT1P1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call